Renata Giorgi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Renata Giorgi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Mario Mariano
Discipline of Immunology, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, Vila Clementino, 04023-900 São Paulo, SP, Brazil ; Discipline of Immunology, Universidade Paulista, Vila Clementino, 04026-002 São Paulo, SP, Brazil
2 shared publicationsRosana L. Pagano
Laboratory of Pathophysiology, Butantan Institute, São Paulo, Brazil
2 shared publicationsBeatriz Helena De Lorenzo
Discipline of Immunology, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, Vila Clementino, 04023-900 São Paulo, SP, Brazil ; Discipline of Immunology, Centro Universitário São Camilo, Ipiranga, 04263-200 São Paulo, SP, Brazil
1 shared publication- Bianca Cestari Zychar
Laboratory of Pathophysiology, Butantan Institute, São Paulo 05503-900, Brazil
1 shared publication Camila S. Dale
Laboratory of Pathophysiology, Butantan Institute, Av Vital Brazil, 1500, São Paulo, São Paulo, SP 05503–900, Brazil
1 shared publicationCamila Squarzoni Dale
Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil 1500, São Paulo, SP 05503-900, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-10
Inhibition of Macrophage Functions by the C-Terminus of Murine S100A9 Is Dependent on B-1 Cells
The protein S100A9 plays a key role in the control of inflammatory response. The C-terminus of the murine S100A9 protein (mS100A9p) downregulates the spreading and phagocytic activity of adherent peritoneal cells. Murine peritoneal cells are constituted by macrophages and B-1 cells, and the latter exert an inhibitory effect on macrophage functions by secreting interleukin- (IL-) 10. Here, we investigated the influence of B-1 cells on the inhibitory effect evoked by mS100A9p on macrophages. mS100A9p did not alter spreading and phagocytosis either by peritoneal macrophages obtained from mice deprived of B-1 cells or by bone marrow-derived macrophages (BMDMϕ). Nevertheless, when BMDMϕwere cocultivated by direct or indirect contact with B-1 cells treated with mS100A9p, the phagocytosis by BMDMϕwas decreased, showing that the effect of mS100A9p on macrophages was modulated by B-1 cells and/or their secretory compounds. Furthermore, the inhibitory action of mS100A9p on phagocytosis by adherent peritoneal cells was abolished in cells obtained from IL-10 knockout mice. Taken together, the results show that mS100A9p has no direct inhibitory effect on macrophages; however, mS100A9p modulates B-1 cells, which in turn downregulates macrophages, at least in part, via IL-10. These data contribute to the characterization of S100A9 functions involving B-1 cells in the regulation of the inflammatory process.
- 1 January 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-10
Open AccessInhibition of Macrophage Functions by the C-Terminus of Murine S100A9 Is Dependent on B-1 Cells
The protein S100A9 plays a key role in the control of inflammatory response. The C-terminus of the murine S100A9 protein (mS100A9p) downregulates the spreading and phagocytic activity of adherent peritoneal cells. Murine peritoneal cells are constituted by macrophages and B-1 cells, and the latter exert an inhibitory effect on macrophage functions by secreting interleukin- (IL-) 10. Here, we investigated the influence of B-1 cells on the inhibitory effect evoked by mS100A9p on macrophages. mS100A9p did not alter spreading and phagocytosis either by peritoneal macrophages obtained from mice deprived of B-1 cells or by bone marrow-derived macrophages (BMDMϕ). Nevertheless, when BMDMϕwere cocultivated by direct or indirect contact with B-1 cells treated with mS100A9p, the phagocytosis by BMDMϕwas decreased, showing that the effect of mS100A9p on macrophages was modulated by B-1 cells and/or their secretory compounds. Furthermore, the inhibitory action of mS100A9p on phagocytosis by adherent peritoneal cells was abolished in cells obtained from IL-10 knockout mice. Taken together, the results show that mS100A9p has no direct inhibitory effect on macrophages; however, mS100A9p modulates B-1 cells, which in turn downregulates macrophages, at least in part, via IL-10. These data contribute to the characterization of S100A9 functions involving B-1 cells in the regulation of the inflammatory process.
- Open Access
- 1 January 2006
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 36765
Neutrophilic Cell‐Free Exudate Induces Antinociception Mediate by the Protein S100A9
Calcium-binding protein S100A9 (MRP-14) induces antinociceptive effect in an experimental model of painful sensibility and participates of antinociception observed during neutrophilic peritonitis induced by glycogen or carrageenan in mice. In this study, the direct antinociceptive role of the protein S100A9 in neutrophilic cell-free exudates obtained of mice injected with glycogen was investigated. Mice were intraperitoneally injected with a glycogen solution, and after , , , and hours, either the pattern of cell migration of the peritoneal exudate or the nociceptive response of animals was evaluated. The glycogen-induced neutrophilic peritonitis evoked antinociception and hours after inoculation of the irritant. Peritoneal cell-free exudates, collected in different times after the irritant injection, were transferred to naive animals which were submitted to the nociceptive test. The transference of exudates also induced antinociceptive effect, and neutralization of S100A9 activity by anti-S100A9 monoclonal antibody totally reverted this response. This effect was not observed when experiments were made or hours after glycogen injection. These results clearly indicate that S100A9 is secreted during glycogen-induced neutrophilic peritonitis, and that this protein is responsible by antinociception observed in the initial phase of inflammatory reaction. Thus, these data reinforce the hypothesis that the calcium-binding protein S100A9 participates of the endogenous control of inflammatory pain.- 1 January 2006
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 36765
Open AccessNeutrophilic Cell‐Free Exudate Induces Antinociception Mediate by the Protein S100A9
Calcium-binding protein S100A9 (MRP-14) induces antinociceptive effect in an experimental model of painful sensibility and participates of antinociception observed during neutrophilic peritonitis induced by glycogen or carrageenan in mice. In this study, the direct antinociceptive role of the protein S100A9 in neutrophilic cell-free exudates obtained of mice injected with glycogen was investigated. Mice were intraperitoneally injected with a glycogen solution, and after , , , and hours, either the pattern of cell migration of the peritoneal exudate or the nociceptive response of animals was evaluated. The glycogen-induced neutrophilic peritonitis evoked antinociception and hours after inoculation of the irritant. Peritoneal cell-free exudates, collected in different times after the irritant injection, were transferred to naive animals which were submitted to the nociceptive test. The transference of exudates also induced antinociceptive effect, and neutralization of S100A9 activity by anti-S100A9 monoclonal antibody totally reverted this response. This effect was not observed when experiments were made or hours after glycogen injection. These results clearly indicate that S100A9 is secreted during glycogen-induced neutrophilic peritonitis, and that this protein is responsible by antinociception observed in the initial phase of inflammatory reaction. Thus, these data reinforce the hypothesis that the calcium-binding protein S100A9 participates of the endogenous control of inflammatory pain. - 1 May 2005
- Published by Springer Nature in Inflammation Research
- Vol. 54 (5) , 204-210
The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells
Objective and design: In the present study, the effect of a synthetic peptide (H92–G102) identical to the C-terminus of murine S100A9 (mS100A9p) was investigated on adherent peritoneal cell function. Materials and methods: For in vitro assays, peritoneal cells were obtained from the abdominal cavity of mice and incubated, with the different concentrations of mS100A9p, for 1 h, and then their spreading and phagocytosis activities were evaluated. For ex-vivo assays, cells obtained from animals treated for 1 h with the peptide were submitted to the mannose-receptor phagocytosis assay. Shorter homologue peptides to the C-terminus of mS100A9p were also evaluated on in vitro phagocytosis assays of Candida albicans particles. Results: mS100A9p reduced both the spreading index and phagocytic activity, in vitro and ex-vivo, independent of the receptor evaluated. The homologue peptide corresponding to the H92–E97 region of mS100A9p, the zinc-binding motif, was responsible for such an effect. Conclusion: These results suggest a modulator effect of the C-terminus of S100A9 protein on the function of adherent peritoneal cells.
- 1 May 2005
- Published by Springer Nature in Inflammation Research
- Vol. 54 (5) , 204-210
The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells
Objective and design: In the present study, the effect of a synthetic peptide (H92–G102) identical to the C-terminus of murine S100A9 (mS100A9p) was investigated on adherent peritoneal cell function. Materials and methods: For in vitro assays, peritoneal cells were obtained from the abdominal cavity of mice and incubated, with the different concentrations of mS100A9p, for 1 h, and then their spreading and phagocytosis activities were evaluated. For ex-vivo assays, cells obtained from animals treated for 1 h with the peptide were submitted to the mannose-receptor phagocytosis assay. Shorter homologue peptides to the C-terminus of mS100A9p were also evaluated on in vitro phagocytosis assays of Candida albicans particles. Results: mS100A9p reduced both the spreading index and phagocytic activity, in vitro and ex-vivo, independent of the receptor evaluated. The homologue peptide corresponding to the H92–E97 region of mS100A9p, the zinc-binding motif, was responsible for such an effect. Conclusion: These results suggest a modulator effect of the C-terminus of S100A9 protein on the function of adherent peritoneal cells.
- Open Access
- 1 January 2002
- Published by Wiley in Mediators of Inflammation
- Vol. 11 (4) , 203-210
Neutrophils and the calcium‐binding protein MRP‐14 mediate carrageenan‐induced antinociception in mice
Background: We have previously shown that the calcium‐binding protein MRP‐14 secreted by neutrophils mediates the antinociceptive response in an acute inflammatory model induced by the intraperitoneal injection of glycogen in mice.Aim: In an attempt to broaden the concept that neutrophils and MRP‐14 controls inflammatory pain induced by different type of irritants, in the present study, after demonstrating that carrageenan (Cg) also induces atinociception in mice, we investigated the participation of both neutrophils and MRP‐14 in the phenomenon.Methods: Male Swiss mice were injected intraperitoneally with Cg and after different time intervals, the pattern of cell migration of the peritoneal exudate and the nociceptive response of animals submitted to the writhing test were evaluated. The participation of neutrophils and of the MRP‐14 on the Cg effect was evaluated by systemic inoculation of monoclonal antibodies anti‐granulocyte and anti‐MRP‐14.Results: Our results demonstrate that the acute neutrophilic peritonitis evoked by Cg induced antinociception 2, 4 and 8 h after inoculation of the irritant. Monoclonal antibodies anti‐granulocyte or anti‐MRP‐14 reverts the antinociceptive response only 2 and 8 h after Cg injection. The antibody anti‐MRP‐14 partially reverts the antinociception observed after 4 h of Cg injection while the anti‐granulocyte antibody enhances this effect. This effect is reverted by simultaneous treatment of the animals with both antibodies. After 4 h of Cg injection in neutrophil‐depleted mice a significant expression of the calcium‐binding protein MRP‐14 was detected in the cytoplasm of peritoneal macrophages. This suggests that the enhancement of the effect observed after treatment with the anti‐neutrophil antibody may be due to secretion of MRP‐14 by macrophages. It has also been demonstrated that endogenous opioids and glucocorticoids are not involved in the antinociception observed at the 4th hour after Cg injection.Conclusion: These data support the hypothesis that neutrophils and the calcium‐binding protein MRP‐14 are participants of the endogenous control of inflammatory pain in mice despite the model of acute inflammation used.
- 1 January 2002
- Published by Wiley in Mediators of Inflammation
- Vol. 11 (4) , 203-210
Open AccessNeutrophils and the calcium‐binding protein MRP‐14 mediate carrageenan‐induced antinociception in mice
Background: We have previously shown that the calcium‐binding protein MRP‐14 secreted by neutrophils mediates the antinociceptive response in an acute inflammatory model induced by the intraperitoneal injection of glycogen in mice.Aim: In an attempt to broaden the concept that neutrophils and MRP‐14 controls inflammatory pain induced by different type of irritants, in the present study, after demonstrating that carrageenan (Cg) also induces atinociception in mice, we investigated the participation of both neutrophils and MRP‐14 in the phenomenon.Methods: Male Swiss mice were injected intraperitoneally with Cg and after different time intervals, the pattern of cell migration of the peritoneal exudate and the nociceptive response of animals submitted to the writhing test were evaluated. The participation of neutrophils and of the MRP‐14 on the Cg effect was evaluated by systemic inoculation of monoclonal antibodies anti‐granulocyte and anti‐MRP‐14.Results: Our results demonstrate that the acute neutrophilic peritonitis evoked by Cg induced antinociception 2, 4 and 8 h after inoculation of the irritant. Monoclonal antibodies anti‐granulocyte or anti‐MRP‐14 reverts the antinociceptive response only 2 and 8 h after Cg injection. The antibody anti‐MRP‐14 partially reverts the antinociception observed after 4 h of Cg injection while the anti‐granulocyte antibody enhances this effect. This effect is reverted by simultaneous treatment of the animals with both antibodies. After 4 h of Cg injection in neutrophil‐depleted mice a significant expression of the calcium‐binding protein MRP‐14 was detected in the cytoplasm of peritoneal macrophages. This suggests that the enhancement of the effect observed after treatment with the anti‐neutrophil antibody may be due to secretion of MRP‐14 by macrophages. It has also been demonstrated that endogenous opioids and glucocorticoids are not involved in the antinociception observed at the 4th hour after Cg injection.Conclusion: These data support the hypothesis that neutrophils and the calcium‐binding protein MRP‐14 are participants of the endogenous control of inflammatory pain in mice despite the model of acute inflammation used.
- 1 July 1991
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 33 (3) , 285-287
Croton zehntneri: possible central nervous system effects in rodents
- 1 July 1991
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 33 (3) , 285-287
Croton zehntneri: possible central nervous system effects in rodents